Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 6/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | F2 | P00734 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | STING1 | Q86WV6 | 1/20 | 0.47 |
| ▸ | MDM2 | Q00987 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6418628 | 1.00 | FFAR1 (0.54) | FFAR1ALDH1A1LMNASMN1; SMN2MAPT | |
| SCHEMBL6413484 | 1.00 | FFAR1 (0.54) | FFAR1ALDH1A1LMNASMN1; SMN2MAPT | |
| SCHEMBL6416757 | 0.80 | FFAR1 (0.56) | FFAR1ALDH1A1MAPTMEN1KMT2A | |
| SCHEMBL6411589 | 0.75 | MDM2 (0.68) | FFAR1ALDH1A1LMNASMN1; SMN2MAPT | |
| SCHEMBL6410237 | 0.75 | FFAR1 (0.61) | FFAR1ALDH1A1LMNASMN1; SMN2MAPT | |
| SCHEMBL6410233 | 0.75 | FFAR1 (0.61) | FFAR1ALDH1A1LMNASMN1; SMN2MAPT | |
| SCHEMBL6417873 | 0.74 | MDM2 (0.51) | FFAR1ALDH1A1LMNASMN1; SMN2MAPT | |
| SCHEMBL3871491 | 0.72 | MAPT (0.76) | FFAR1ALDH1A1MAPTSTING1MDM2 | |
| SCHEMBL10742804 | 0.70 | ALDH1A1 (0.52) | ALDH1A1LMNASMN1; SMN2MAPTF2 | |
| SCHEMBL3928404 | 0.70 | ALDH1A1 (0.58) | ALDH1A1LMNASMN1; SMN2MAPTF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050124614-A1 | 3,4-Dihydroisoquinolin-1-one derivatives as inducers of apoptosis | AXYS PHARMACEUTICALS, INC. (US) | 2005-06-09 | — | — | US | disclosed |
| WO-2004004727-A1 | 3,4-DIHYDROISOQUINOLIN-1-ONE DERIVATIVES AS INDUCERS OF APOPTOSIS | AXYS PHARMACEUTICALS, INC. (US) | 2004-01-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050124614-A1 | 3,4-Dihydroisoquinolin-1-one derivatives as inducers of apoptosis | CASP3, BAX, BAD | FFAR1 3873/4885ALDH1A1 1368/4885LMNA 623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.